This article explores the implications of evolving standards for the type and quality of evidence required of economic experts presenting testimony on class certification motions in antitrust damages cases.
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...
